- Home
- PDS vs VIR Comparison
PDS vs VIR Comparison
Compare PDS & VIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PDS
- VIR
- Stock Information
- Founded
- PDS 1951
- VIR 2016
- Country
- PDS Canada
- VIR United States
- Employees
- PDS N/A
- VIR N/A
- Industry
- PDS
- VIR Biotechnology: Pharmaceutical Preparations
- Sector
- PDS
- VIR Health Care
- Exchange
- PDS Nasdaq
- VIR Nasdaq
- Market Cap
- PDS 649.5M
- VIR 844.9M
- IPO Year
- PDS N/A
- VIR 2019
- Fundamental
- Price
- PDS $50.53
- VIR $5.47
- Analyst Decision
- PDS Buy
- VIR Strong Buy
- Analyst Count
- PDS 1
- VIR 7
- Target Price
- PDS $95.00
- VIR $32.86
- AVG Volume (30 Days)
- PDS 118.1K
- VIR 1.2M
- Earning Date
- PDS 07-29-2025
- VIR 07-31-2025
- Dividend Yield
- PDS N/A
- VIR N/A
- EPS Growth
- PDS N/A
- VIR N/A
- EPS
- PDS 5.20
- VIR N/A
- Revenue
- PDS $1,301,611,298.00
- VIR $20,861,000.00
- Revenue This Year
- PDS $1.35
- VIR N/A
- Revenue Next Year
- PDS $0.99
- VIR N/A
- P/E Ratio
- PDS $9.02
- VIR N/A
- Revenue Growth
- PDS N/A
- VIR N/A
- 52 Week Low
- PDS $36.20
- VIR $4.32
- 52 Week High
- PDS $79.07
- VIR $14.45
- Technical
- Relative Strength Index (RSI)
- PDS 62.11
- VIR 55.40
- Support Level
- PDS $46.44
- VIR $4.91
- Resistance Level
- PDS $47.83
- VIR $5.35
- Average True Range (ATR)
- PDS 1.59
- VIR 0.25
- MACD
- PDS -0.07
- VIR 0.03
- Stochastic Oscillator
- PDS 74.75
- VIR 86.21
About PDS Precision Drilling Corporation
Precision Drilling Corp is a provider of contract drilling and completion and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. Contract Drilling Services include drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale and repair of drilling equipment. Completion and Production Services include service rigs, oilfield equipment rental, and camp and catering services.
About VIR Vir Biotechnology Inc.
Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.